Skip to content

Clinical trials

Completed Atherosclerosis trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Status: Completed Country / region: Norway Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20081
20102
20111
20121
20182
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline2
Ullevaal University Hospital2
University Hospital, Akershus2
Amgen1
Bayer1
CSL Behring1
Ionis Pharmaceuticals, Inc.1
Novartis Pharmaceuticals1
Oslo University Hospital1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis13
Cardiovascular Diseases5
Coronary Artery Disease4
Stroke3
Coronary Disease2
Heart Diseases2
Inflammation2
Ischemic Stroke2
Peripheral Arterial Disease2
Acute Coronary Syndrome1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.